Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Clayman

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Journal of Cellular Physiology|May 31, 2001
Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated geneB Guan, P Yue, G L Clayman, et al.
Japanese Journal of Clinical Oncology|December 9, 1997
Report of the Tenth International Symposium of the Foundation for Promotion of Cancer Research: Basic and Clinical Research in Head and Neck cancerG L Clayman, S Ebihara, M Terada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancersG L Clayman, D K Frank, P A Bruso, et al.
The Journal of Laryngology and Otology|September 12, 2012
Prognostic value of cathepsin L and its inhibitor headpin in oral squamous cell carcinomaT Nakashima, R Yasumatsu, M Masuda, et al.
Cancer Research|July 29, 1998
Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimensK V Woods, A El-Naggar, G L Clayman, et al.
Head & Neck|November 1, 1993
Bacteriologic profile of surgical infection after antibiotic prophylaxisG L Clayman, I I Raad, P D Hankins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neckD K Frank, T J Liu, M J Frederick, et al.
Head & Neck|June 22, 2000
Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirusY C Henderson, R L Breau, T J Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neckD K Frank, M J Frederick, T J Liu, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 26, 1999
DNA repair in lymphoblastoid cell lines from patients with head and neck cancerE M Sturgis, G L Clayman, Y Guan, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Journal of Cellular Physiology|May 31, 2001
Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated geneB Guan, P Yue, G L Clayman, et al.
Japanese Journal of Clinical Oncology|December 9, 1997
Report of the Tenth International Symposium of the Foundation for Promotion of Cancer Research: Basic and Clinical Research in Head and Neck cancerG L Clayman, S Ebihara, M Terada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancersG L Clayman, D K Frank, P A Bruso, et al.
The Journal of Laryngology and Otology|September 12, 2012
Prognostic value of cathepsin L and its inhibitor headpin in oral squamous cell carcinomaT Nakashima, R Yasumatsu, M Masuda, et al.
Cancer Research|July 29, 1998
Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimensK V Woods, A El-Naggar, G L Clayman, et al.
Head & Neck|November 1, 1993
Bacteriologic profile of surgical infection after antibiotic prophylaxisG L Clayman, I I Raad, P D Hankins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neckD K Frank, T J Liu, M J Frederick, et al.
Head & Neck|June 22, 2000
Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirusY C Henderson, R L Breau, T J Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neckD K Frank, M J Frederick, T J Liu, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 26, 1999
DNA repair in lymphoblastoid cell lines from patients with head and neck cancerE M Sturgis, G L Clayman, Y Guan, et al.
Pageof 10